BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27069125)

  • 21. A somatic mutation of the KEAP1 gene in malignant melanoma is involved in aberrant NRF2 activation and an increase in intrinsic drug resistance.
    Miura S; Shibazaki M; Kasai S; Yasuhira S; Watanabe A; Inoue T; Kageshita Y; Tsunoda K; Takahashi K; Akasaka T; Masuda T; Maesawa C
    J Invest Dermatol; 2014 Feb; 134(2):553-556. PubMed ID: 23938463
    [No Abstract]   [Full Text] [Related]  

  • 22. Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression.
    Liu Y; Chan F; Sun H; Yan J; Fan D; Zhao D; An J; Zhou D
    Eur J Pharmacol; 2011 Jan; 650(1):130-7. PubMed ID: 20951123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nrf2 activation in the liver of rats subjected to a preconditioning sub-chronic iron protocol.
    Morales P; Vargas R; Videla LA; Fernández V
    Food Funct; 2014 Feb; 5(2):243-50. PubMed ID: 24346829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the Nrf2 and Keap1 proteins and their clinical significance in osteosarcoma.
    Zhang J; Wang X; Wu W; Dang H; Wang B
    Biochem Biophys Res Commun; 2016 Apr; 473(1):42-46. PubMed ID: 26987716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
    Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
    Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM; Kruszewski MK
    Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
    Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
    Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity.
    Ji LL; Sheng YC; Zheng ZY; Shi L; Wang ZT
    Free Radic Biol Med; 2015 Aug; 85():12-23. PubMed ID: 25881548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of UVB-induced sunburn reaction and oxidative DNA damage with no alterations in UVB-induced skin carcinogenesis in Nrf2 gene-deficient mice.
    Kawachi Y; Xu X; Taguchi S; Sakurai H; Nakamura Y; Ishii Y; Fujisawa Y; Furuta J; Takahashi T; Itoh K; Yamamoto M; Yamazaki F; Otsuka F
    J Invest Dermatol; 2008 Jul; 128(7):1773-9. PubMed ID: 18200051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
    Sun Z; Zhang S; Chan JY; Zhang DD
    Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Keap1-Nrf2 system and diabetes mellitus.
    Uruno A; Yagishita Y; Yamamoto M
    Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Nrf2 might reduce oxidative stress in human granulosa cells.
    Akino N; Wada-Hiraike O; Terao H; Honjoh H; Isono W; Fu H; Hirano M; Miyamoto Y; Tanikawa M; Harada M; Hirata T; Hirota Y; Koga K; Oda K; Kawana K; Fujii T; Osuga Y
    Mol Cell Endocrinol; 2018 Jul; 470():96-104. PubMed ID: 28986302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischemic injury promotes Keap1 nitration and disturbance of antioxidative responses in endothelial cells: a potential vasoprotective effect of melatonin.
    Tao RR; Huang JY; Shao XJ; Ye WF; Tian Y; Liao MH; Fukunaga K; Lou YJ; Han F; Lu YM
    J Pineal Res; 2013 Apr; 54(3):271-81. PubMed ID: 22946793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.
    Jubb AM; Ribas A; Sosman JA; McArthur GA; Yan Y; Rost S; Zhao S; Koeppen H
    Histopathology; 2013 Sep; 63(3):351-61. PubMed ID: 23802768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could physical exercises modulate Nrf2-Keap1 pathway in chronic kidney disease?
    Abreu CC; Cardozo LF; Mafra D
    Med Hypotheses; 2015 Jan; 84(1):44-6. PubMed ID: 25466297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.
    Nakai K; Fujii H; Kono K; Goto S; Kitazawa R; Kitazawa S; Hirata M; Shinohara M; Fukagawa M; Nishi S
    Am J Hypertens; 2014 Apr; 27(4):586-95. PubMed ID: 24025724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
    Kim HJ; Vaziri ND
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrachlorobenzoquinone activates Nrf2 signaling by Keap1 cross-linking and ubiquitin translocation but not Keap1-Cullin3 complex dissociation.
    Su C; Zhang P; Song X; Shi Q; Fu J; Xia X; Bai H; Hu L; Xu D; Song E; Song Y
    Chem Res Toxicol; 2015 Apr; 28(4):765-74. PubMed ID: 25742418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.